MedPath

The EARLY study: Early detection of acute and early-onset cARdiovascuLar toxicitY in children with cancer using a multiparametric approach.

Completed
Conditions
cardiomyopathy
heart failure
10082206
Registration Number
NL-OMON49327
Lead Sponsor
Prinses Máxima Centrum voor Kinderoncologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1) 100 children with cancer receiving anthracyclines according to their
treatment protocol
2) A subgroup of 30 children, aged > 8 years, diagnosed with Hodgkin Lymphoma,
Ewing Sarcoma, Osteosarcoma or Soft Tissue Sarcoma who have MRI evaluation as
part of their tumor response evaluation.
3) a signed informed consent

Exclusion Criteria

Children with
1) severe comorbidity
2) congenital heart disease
3) a history of thoracic radiation or chemotherapy for other malignancies
4) general contraindications for MRI for the patients in the MRI study group.
5) Patients who need anaesthesia for MRI scanning

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath